Exelon (EXC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
For the quarter ended June 2025, Exelon (EXC) reported revenue of $5.43 billion, up 1.2% over the same period last year. EPS came in at $0.39, compared to $0.47 in the year-ago quarter.The reported revenue represents a surprise of -1.91% over the Zacks Consensus Estimate of $5.53 billion. With the consensus EPS estimate being $0.37, the EPS surprise was +5.41%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Exelon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Operating revenues- PECO: $1 billion compared to the $984.62 million average estimate based on three analysts. The reported number represents a change of +12.2% year over year.Operating revenues- ComEd: $1.84 billion compared to the $2.05 billion average estimate based on three analysts. The reported number represents a change of -11.7% year over year.Operating revenues- BGE: $1.03 billion compared to the $999.01 million average estimate based on three analysts. The reported number represents a change of +10.9% year over year.Operating revenues- PHI: $1.58 billion compared to the $1.51 billion average estimate based on three analysts. The reported number represents a change of +7.3% year over year.Electric revenues- ComEd: $2.06 billion versus the three-analyst average estimate of $2.05 billion. The reported number represents a year-over-year change of -3%.Electric revenues- ACE: $397 million versus the two-analyst average estimate of $376.69 million. The reported number represents a year-over-year change of -1.7%.Electric revenues- DPL: $387 million versus the two-analyst average estimate of $380.36 million. The reported number represents a year-over-year change of +7.2%.Electric revenues- Pepco: $791 million compared to the $728.13 million average estimate based on two analysts. The reported number represents a change of +14.5% year over year.Natural gas revenues- PECO: $120 million compared to the $136.18 million average estimate based on two analysts. The reported number represents a change of +29% year over year.Electric revenues- BGE: $853 million versus $829.28 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.Electric revenues- PECO: $872 million versus $886.01 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +10% change.Natural gas revenues- BGE: $184 million compared to the $195.24 million average estimate based on two analysts. The reported number represents a change of +22.7% year over year.View all Key Company Metrics for Exelon here>>>Shares of Exelon have returned +3.1% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelon Corporation (EXC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Exelon und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Exelon
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Exelon
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Exelon Corp.
Analysen zu Exelon Corp.
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Exelon Overweight | Barclays Capital | |
24.07.2018 | Exelon Sector Outperform | Scotia Howard Weil | |
23.01.2018 | Exelon Neutral | Mizuho | |
15.05.2017 | Exelon Buy | UBS AG | |
13.10.2016 | Exelon Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Exelon Overweight | Barclays Capital | |
24.07.2018 | Exelon Sector Outperform | Scotia Howard Weil | |
15.05.2017 | Exelon Buy | UBS AG | |
24.03.2016 | Exelon Overweight | Barclays Capital | |
07.03.2016 | Exelon Buy | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2018 | Exelon Neutral | Mizuho | |
13.10.2016 | Exelon Neutral | UBS AG | |
13.01.2016 | Exelon Neutral | UBS AG | |
17.11.2015 | Exelon Sector Perform | Scotia Howard Weil | |
26.08.2015 | Exelon Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2012 | Exelon sell | UBS AG | |
12.09.2012 | Exelon sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Exelon Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen